These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3406978)

  • 21. Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats.
    Kim JY; Suh KS
    J Korean Med Sci; 1995 Oct; 10(5):352-9. PubMed ID: 8750061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine-induced renal structural damage: influence of dosage, strain, age and sex with reference to the rat and guinea pig.
    Duncan JI; Thomson AW; Aldridge RD; Simpson JG; Whiting PH
    Clin Nephrol; 1986; 25 Suppl 1():S14-7. PubMed ID: 3708924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.
    Vieira JM; Noronha IL; Malheiros DM; Burdmann EA
    Transplantation; 1999 Dec; 68(11):1746-53. PubMed ID: 10609952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model.
    Andoh TF; Burdmann EA; Lindsley J; Houghton DC; Bennett WM
    Transplantation; 1994 Feb; 57(4):483-9. PubMed ID: 7509514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats.
    Kon V; Hunley TE; Fogo A
    Transplantation; 1995 Jul; 60(1):89-95. PubMed ID: 7624949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy.
    Ryffel B; Müller AM; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S121-5. PubMed ID: 3708922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin A-induced nephrotoxicity in the rat: relationship to increased plasma renin activity.
    McAuley FT; Simpson JG; Thomson AW; Whiting PH
    Agents Actions; 1987 Jun; 21(1-2):209-16. PubMed ID: 3307341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity.
    Schnabel FR; Wait RB; Kahng KU
    Transplantation; 1991 Mar; 51(3):686-9. PubMed ID: 2006526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K
    Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
    Hagar HH; El Etter E; Arafa M
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):189-96. PubMed ID: 16487261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic cyclosporin A (CsA) nephrotoxicity in the rat: the effect of calcium blockade with verapamil.
    Shaikh MG; Heys SD; Brown PA; Whiting PH
    Int J Exp Pathol; 1993 Aug; 74(4):389-96. PubMed ID: 8398812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.
    Grieve EM; Hawksworth GM; Simpson JG; Whiting PH
    Biochem Pharmacol; 1990 Nov; 40(10):2323-9. PubMed ID: 2244933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of Mizoribine on Cyclosporine A nephropathy in rats.
    Hara S; Umino D; Someya T; Fujinaga S; Ohtomo Y; Murakami H; Shimizu T
    Pediatr Res; 2009 Nov; 66(5):524-7. PubMed ID: 19668109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine A-induced kidney alterations are limited by melatonin in rats: an electron microscope study.
    Stacchiotti A; Lavazza A; Rezzani R; Bianchi R
    Ultrastruct Pathol; 2002; 26(2):81-7. PubMed ID: 12036096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
    Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of vitamin E and/or quercetin in attenuating chronic cyclosporine A-induced nephrotoxicity in male rats.
    Zal F; Mostafavi-Pour Z; Vessal M
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):720-4. PubMed ID: 17600547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity.
    Shihab FS; Yi H; Bennett WM; Andoh TF
    Kidney Int; 2000 Sep; 58(3):1174-85. PubMed ID: 10972680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective enhancement of thromboxane in macrophages and kidneys in cyclosporine-induced nephrotoxicity. Dietary protection by fish oil.
    Rogers TS; Elzinga L; Bennett WM; Kelley VE
    Transplantation; 1988 Jan; 45(1):153-6. PubMed ID: 3422115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cyclosporin nephrotoxicity in the rat: effects on renal function and morphology.
    Dieperink H; Leyssac PP; Starklint H; Kemp E
    Nephrol Dial Transplant; 1988; 3(3):317-26. PubMed ID: 3140107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.